A double-blind, placebo-controlled review made use of intravenous allogeneic human MSCs in fifty three submit-MI patients, with similar adverse gatherings between each groups. Ambulatory EKG showed minimized episodes of ventricular tachycardia, and also improved compelled expiratory volume in one 2nd on pulmonary purpose testing during the group th